NDRA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 mai 2024 @ 22:00):

Stats
Dagens volum	110 731
Gjennomsnittsvolum	186 909
Markedsverdi	3.34M
EPS	$0 ( 2024-05-14 )
Neste inntjeningsdato	( $-0.270 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.330
ATR14	$0.00500 (1.65%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Basenese Lou	Buy	600	Stock Options
2024-01-02	Harsh Michael	Buy	600	Stock Options
2024-01-02	Digiandomenico Anthony	Buy	600	Stock Options
2024-01-02	Tokman Alexander Y	Buy	600	Stock Options
2023-05-18	Thornton Michael Milos	Buy	15 000	Common Stock

INSIDER POWER
100.00
Last 100 transactions
Buy: 3 706 167 \| Sell: 432 712

Volum Korrelasjon

Lang: -0.25 (neutral)

Kort: 0.52 (weak)

Signal:(51.237) Neutral

ENDRA Life Sciences Inc Korrelasjon

10 Mest positive korrelasjoner
JWEL	0.943
LULU	0.93
SHC	0.923
EZGO	0.921
GOCO	0.916
IMRX	0.916
DCFC	0.915
AZ	0.915
DXLG	0.915
ASPS	0.913

10 Mest negative korrelasjoner
KEQU	-0.944
EML	-0.93
IVCB	-0.929
SWAV	-0.929
FUSN	-0.927
CDXC	-0.907
LABP	-0.907
PESI	-0.905
BCSA	-0.904
IMPPP	-0.904

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

ENDRA Life Sciences Inc Korrelasjon - Valuta/Råvare

0.14
( neutral )

0.10
( neutral )

0.00
( neutral )

0.15
( neutral )

ENDRA Life Sciences Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-275 451 (0.00 %)
EPS:	$-1.580

FY	2023
Omsetning:	$0
Bruttogevinst:	$-275 451 (0.00 %)
EPS:	$-1.580

FY	2022
Omsetning:	$0
Bruttogevinst:	$-234 258 (0.00 %)
EPS:	$-4.57

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-11.83

Financial Reports:

No articles found.

ENDRA Life Sciences Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ENDRA Life Sciences Inc

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.